Natural Ingredients and Products Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Phil International

R&D FOR SOFTGELS

Based on customer requirements or product concept, we, R&D Center under PHIL International, work through organized process for each phase of developing and studying. The development scope can be flexibly enlarged or reduced upon a contract made with customers; gel and fill formula, trial encapsulation, scale-up to commercial batch, specifications and test procedures, manufacturing process, stability studies,
validation protocol and report, etc.

Our developments including on-going studies are specified as follow:

  • Aceclofenac 100 mg
  • Clotrimazole 100 mg, 500 mg
  • Naproxen 250 mg
  • Ursodeoxycholic acid 150 mg, 200 mg, 300 mg
  • Dexibuprofen 300 mg
  • Pamidronate 100 mg
  • Clonixin lysinate 125 mg
  • Artesunate 50 mg + Amodiaquine HCl 200 mg
  • Piroxicam 20 mg
  • Artemether 20 mg + Lumefantrine 120 mg
  • Sildenafil 50 mg
  • Artemether 80 mg + Lumefantrine 480 mg
  • Dihydroxydibutyl ether 500 mg
  • Donepezil 5 mg, 10mg
  • Chewable softgel for dietary supplements
View this product at philintl.com
Feedback